Empasmart-Lina Tablets (Empagliflozin and Linagliptin )
Empasmart-Lina Tablets combine empagliflozin and linagliptin to help control blood sugar in adults with type 2 diabetes and reduce the risk of heart-related complications.
Introduction Of Empasmart-Lina Tablets
Empasmart-Lina Tablets combine two antidiabetic agents:
Empagliflozin: An SGLT2 inhibitor that lowers blood sugar by promoting glucose excretion through urine.
Linagliptin: A DPP-4 inhibitor that increases insulin secretion and decreases glucagon release, helping to lower blood sugar.
This combination is used alongside diet and exercise to improve blood sugar control in adults with type 2 diabetes and reduce the risk of cardiovascular events in those with existing heart disease.
Precautions Of Empasmart-Lina Tablets
- Not recommended for individuals with type 1 diabetes mellitus or severe renal impairment.
- Use with caution in patients with a history of pancreatitis.
- Monitor for signs of ketoacidosis, especially in those with risk factors.
- Discontinue if signs of severe hypersensitivity reactions occur.
Uses Of Empasmart-Lina Tablets
- Type 2 Diabetes Management: Helps lower blood sugar in adults with type 2 diabetes.
- Cardiovascular Risk Reduction: Reduces the risk of heart-related complications in patients with type 2 diabetes and established heart disease.
- Adjunct to Diet & Exercise: Works alongside lifestyle changes to improve glycemic control.
Side Effects Of Empasmart-Lina Tablets
Common:
- Urinary tract infections
- Genital fungal infections
- Increased urination
- Nausea
- Dizziness
Serious:
- Ketoacidosis
- Pancreatitis
- Severe allergic reactions
- Dehydration
- Low blood pressure
- Kidney issues
FAQs Of Empasmart-Lina Tablets
Q1: What is Empasmart-Lina used for?
It is used to control blood sugar in type 2 diabetes and reduce cardiovascular risk in patients with heart disease.
Q2: How should I take it?
Take as prescribed by your doctor, with or without food, usually once daily.
Q3: What if I miss a dose?
Take it as soon as you remember unless it’s almost time for your next dose. Do not double doses.
Q4: Can I drink alcohol while on this medication?
Alcohol may increase the risk of low blood sugar, so it should be limited.
Q5: What are the common side effects?
Urinary tract infections, genital fungal infections, increased urination, nausea, and dizziness.
Q6: Who should avoid this medicine?
People with type 1 diabetes, severe kidney problems, or a history of pancreatitis should avoid it.
Q7: Can it be used during pregnancy or breastfeeding?
Consult a doctor before use, as safety in pregnancy or breastfeeding is not well established.
Interactions Of Empasmart-Lina Tablets
- Other diabetes medicines (insulin, sulfonylureas): May cause low blood sugar.
- Diuretics & blood pressure drugs: Risk of dehydration or low blood pressure.
- Kidney-affecting drugs (NSAIDs, ACE inhibitors): May increase kidney problems.
- CYP3A4 drugs (ketoconazole, rifampicin): Can affect linagliptin levels.
- Alcohol: Increases risk of low blood sugar.
| Manufacturer | : | Healing Pharma |
| Trade Name | : | |
| Generic Search | : | Empagliflozin and Linagliptin |
| Strength | : | 10mg + 5mg , 25mg + 5mg |












